BRIEF-Cardiome Q1 loss per share $0.06

Fri May 13, 2016 7:07am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 13 (Reuters) - Cardiome Pharma Corp :

* Anticipate our first commercial sales of XYDALBA this year and a larger commercial roll-out during 2017

* Cardiome reports first quarter 2016 financial results

* Q1 loss per share $0.06

* Q1 revenue $7.1 million versus I/B/E/S view $6.3 million

* Q1 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)